Topical bromfenac for prevention and treatment of cystoid macular edema following cataract surgery: a review

por Sheppard, John D
Publicado 2016

Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape

por Sheppard, John D., Nichols, Kelly K.
Publicado 2023

Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis

por Williams, Patricia B, Crandall, Elizabeth, Sheppard, John D
Publicado 2010

Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure

por Sheppard, John D., Comstock, Timothy L., Cavet, Megan E.
Publicado 2016

An update on the surgical management of pterygium and the role of loteprednol etabonate ointment

por Sheppard, John D, Mansur, Arnulfo, Comstock, Timothy L, Hovanesian, John A
Publicado 2014

In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits

por Sheppard, John D., Cockrum, Paul C., Justice, Angela, Jasek, Mark C.
Publicado 2018

Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant

por Sheppard, John D, Nguyen, Quan Dong, Usner, Dale W, Comstock, Timothy L
Publicado 2012

Reproxalap Improves Signs and Symptoms of Allergic Conjunctivitis in an Allergen Chamber: A Real-World Model of Allergen Exposure

por Clark, David, Karpecki, Paul, Salapatek, Anne Marie, Sheppard, John D, Brady, Todd C
Publicado 2022

An Evaluation of Staphylococci from Ocular Surface Infections Treated Empirically with Topical Besifloxacin: Antibiotic Resistance, Molecular Characteristics, and Clinical Outcomes

por Schechter, Barry A., Sheppard, John D., Sanfilippo, Christine M., DeCory, Heleen H., Asbell, Penny A.
Publicado 2019

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease

por Taylor, Mike, Ousler, George, Torkildsen, Gail, Walshe, Claire, Fyfe, Matthew C T, Rowley, Adele, Webber, Steve, Sheppard, John D, Duggal, Ajay
Publicado 2019

Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal Dystrophy

por Lindstrom, Richard L., Lewis, Amber E., Holland, Edward J., Sheppard, John D., Hovanesian, John A., Senchyna, Michelle, Hollander, David A.
Publicado 2022

Phialophora chinensis fungal keratitis: An initial case report and species identification

por Ply, Briana, Cañete-Gibas, Connie F., Sanders, Carmita, Wiederhold, Nathan P., Dandar, Rachel A., Sheppard, John D., Cheung, Albert Y.
Publicado 2023

Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial

por Akpek, Esen K., Wirta, David L., Downing, Johnathon E., Tauber, Joseph, Sheppard, John D., Ciolino, Joseph B., Meides, Alice S., Krösser, Sonja
Publicado 2023

A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study

por Sheppard, John D., Wirta, David L., McLaurin, Eugene, Boehmer, Blair E., Ciolino, Joseph B., Meides, Alice S., Schlüter, Thomas, Ousler, George W., Usner, Dale, Krösser, Sonja
Publicado 2021

Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?

por Sheppard, John D., O'Dell, Leslie E., Karpecki, Paul M., Raizman, Michael B., Whitley, Walter O., Blemker, Gretchen, Hemphill, Mandy, Hendrix, Laura H., Gibson, Andrea, Macsai, Marian
Publicado 2023